Home › Asthma › California › Long Beach
Asthma clinical trials in Long Beach, CA
4 studies for Asthma are looking for participants at sites in and around Long Beach (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
RecruitingPhase 3
- Research Site, Long Beach
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
RecruitingPhase 3
- Teva Investigational Site 12145, Long Beach
A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
RecruitingPhase 2
- Research Site, Long Beach
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
RecruitingPhase 3
- Research Site, Long Beach
- Research Site, Long Beach
About Asthma
Asthma causes one's airways to become sore and swollen. An attack means a person's lungs are getting less air. Learn about two types of treatment.
More about Asthma on MedlinePlus
Asthma trials in other cities
- Miami, FL12 studies
- Boston, MA11 studies
- New York City, NY11 studies
- Dallas, TX10 studies
- Oklahoma City, OK10 studies
- Durham, NC10 studies
- Washington, DC9 studies
- The Bronx, NY9 studies
- Kansas City, KS8 studies
- Houston, TX8 studies
- Pittsburgh, PA7 studies
- Tampa, FL7 studies
Other studies in Long Beach
- Non-Small Cell Lung Cancer12 studies
- Type 2 Diabetes11 studies
- Breast Cancer9 studies
- Lung Cancer9 studies
- Alzheimer's Disease8 studies
- Prostate Cancer7 studies
- Cancer (all types)6 studies
- Cardiovascular Disease6 studies
- Dementia5 studies
- Obesity5 studies
- Overweight5 studies
- Chronic Lymphocytic Leukemia4 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.